Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA

por Seubert, C M, Stritzker, J, Hess, M, Donat, U, Sturm, J B, Chen, N, Hof, J M von, Krewer, B, Tietze, L F, Gentschev, I, Szalay, A A
Publicado 2011